Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

678.12 -14.56 (-2.10%)

Delayed Quote Updated: 3:16 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

17 18 Next >

Sherwin-Williams Posts Weak Results, Joins Logitech And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

October 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 22, 2024

Via Benzinga

Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗

October 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 21, 2024

Via Benzinga

Insights Ahead: Medpace Hldgs's Quarterly Earnings ↗

October 18, 2024

Via Benzinga

Exploring Medpace Hldgs's Earnings Expectations ↗

October 18, 2024

Via Benzinga

Earnings Preview For Medpace Hldgs ↗

October 18, 2024

Via Benzinga

Medpace Holdings, Inc. Reports Third Quarter 2024 Results

October 21, 2024

From Medpace Holdings, Inc.

Via Business Wire

Examining the Future: Medpace Hldgs's Earnings Outlook ↗

October 18, 2024

Via Benzinga

A Look at Medpace Hldgs's Upcoming Earnings Report ↗

October 18, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Medpace Hldgs ↗

October 14, 2024

Via Benzinga

Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Centuri, Medpace, and Franklin and Encourages Investors to Contact the Firm

October 08, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Looking Into Medpace Hldgs's Recent Short Interest ↗

October 01, 2024

Via Benzinga

Assessing Medpace Hldgs: Insights From 9 Financial Analysts ↗

September 27, 2024

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,000 Today ↗

September 27, 2024

Via Benzinga

MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the Firm

October 08, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Cardlytics, Medpace, Customers Bancorp, and Ibotta and Encourages Investors to Contact the Firm

September 30, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the Firm

September 30, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Cracking The Code: Understanding Analyst Reviews For Medpace Hldgs ↗

September 11, 2024

Via Benzinga

Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio? ↗

September 29, 2024

10 worst performing large-cap stocks last week: SMMT, MMYT, MEDP, REGN, GPN, AFRM, SMCI, FTI, FCNCA, NOW. Are they in your portfolio?

Via Benzinga

Medpace Holdings, Inc. to Report Third Quarter 2024 Financial Results on October 21, 2024

September 24, 2024

From Medpace Holdings, Inc.

Via Business Wire

How to Analyze a Balance Sheet ↗

September 07, 2024

Real-life examples to help investors make sense of this critical document.

Via The Motley Fool

Here's How Much You Would Have Made Owning Medpace Hldgs Stock In The Last 5 Years ↗

September 05, 2024

Via Benzinga

If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today ↗

August 21, 2024

Via Benzinga

If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today ↗

August 09, 2024

Via Benzinga

Bragar Eagel & Squire, P.C. Is Investigating Centuri, Medpace, Customers Bancorp, and Globus and Encourages Investors to Contact the Firm

August 30, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating Dril-Quip, LPL Financial, Methode, and Medpace and Encourages Investors to Contact the Firm

August 19, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Thermo Fisher Scientific Stock Sees RS Rating Jump To 81 ↗

August 13, 2024

Thermo Fisher Scientific stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 77 to 81.

Via Investor's Business Daily

The Investing Mosaic ↗

August 07, 2024

How do you determine what a company's worth? You start by pulling a lot of information from a lot of different places.

Via The Motley Fool

MEDPACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Medpace Holdings, Inc. on Behalf of Medpace Stockholders and Encourages Investors to Contact the Firm

August 02, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.